350 related articles for article (PubMed ID: 16121311)
1. Current insights on the pathogenesis of pulmonary arterial hypertension.
Perros F; Dorfmüller P; Humbert M
Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
[TBL] [Abstract][Full Text] [Related]
4. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
[TBL] [Abstract][Full Text] [Related]
5. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study.
Can MM; Tanboğa IH; Demircan HC; Ozkan A; Koca F; Keleş N; Sönmez K; Kaymaz C; Serebruany V
Thromb Res; 2010 Oct; 126(4):280-2. PubMed ID: 20673969
[TBL] [Abstract][Full Text] [Related]
6. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
[TBL] [Abstract][Full Text] [Related]
7. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.
Gurbanov E; Shiliang X
Eur J Cardiothorac Surg; 2006 Sep; 30(3):499-507. PubMed ID: 16870458
[TBL] [Abstract][Full Text] [Related]
8. [Physiopathology of pulmonary arterial hypertension. Cellular and molecular aspects].
Perros F; Humbert M
Presse Med; 2005 Feb; 34(3):232-42. PubMed ID: 15798538
[TBL] [Abstract][Full Text] [Related]
9. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Dumas de la Roque E; Savineau JP; Bonnet S
Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
[TBL] [Abstract][Full Text] [Related]
11. Current therapeutics and practical management strategies for pulmonary arterial hypertension.
Agarwal R; Gomberg-Maitland M
Am Heart J; 2011 Aug; 162(2):201-13. PubMed ID: 21835279
[TBL] [Abstract][Full Text] [Related]
12. Cellular pathophysiology and therapy of pulmonary hypertension.
Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
[TBL] [Abstract][Full Text] [Related]
13. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
14. L-Arginine inhibiting pulmonary vascular remodelling is associated with promotion of apoptosis in pulmonary arterioles smooth muscle cells in broilers.
Tan X; Pan JQ; Li JC; Liu YJ; Sun WD; Wang XL
Res Vet Sci; 2005 Dec; 79(3):203-9. PubMed ID: 16054890
[TBL] [Abstract][Full Text] [Related]
15. Pathologic assessment of vasculopathies in pulmonary hypertension.
Pietra GG; Capron F; Stewart S; Leone O; Humbert M; Robbins IM; Reid LM; Tuder RM
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):25S-32S. PubMed ID: 15194175
[TBL] [Abstract][Full Text] [Related]
16. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
[TBL] [Abstract][Full Text] [Related]
17. Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension.
Jernigan NL; Resta TC; Gonzalez Bosc LV
Adv Exp Med Biol; 2017; 967():83-103. PubMed ID: 29047083
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.
Farkas L; Gauldie J; Voelkel NF; Kolb M
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):1-15. PubMed ID: 21057104
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension.
Jeffery TK; Morrell NW
Prog Cardiovasc Dis; 2002; 45(3):173-202. PubMed ID: 12525995
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension in children: a historical overview.
Abman SH
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S4-9. PubMed ID: 20216162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
